Oracle Corp. (NYSE:ORCL) is reportedly preparing a massive capital raise of up to $50 billion to accelerate its expansion of cloud infrastructure. Oracle Targets Up To $50 Billion To Expand Cloud Capacity On Sunday, Oracle said it plans to raise $45 billion to $50 billion in 2026 to build additional capacity for its cloud infrastructure. "Oracle is raising money in order to build additional capaci...
Oracle Corp. (NYSE:ORCL) is reportedly preparing a massive capital raise of up to $50 billion to accelerate its expansion of cloud infrastructure. Oracle Targets Up To $50 Billion To Expand Cloud Capacity On Sunday, Oracle said it plans to raise $45 billion to $50 billion in 2026 to build additional capacity for its cloud infrastructure. "Oracle is raising money in order to build additional capacity to meet the contracted demand from our largest Oracle Cloud Infrastructure customers," the company said in a statement. The funding will be split roughly evenly between equity and debt, marking one of the largest capital-raising efforts in Oracle's history. Equity Sales, Convertibles And One-Time Bond Issuance Planned On the equity side, Oracle plans to raise about half of the funds through equity-linked and common stock issuances. This includes mandatory convertible preferred securities, along with an at-the-market equity program of up to $20 billion. For debt financing, Oracle intends to complete a single, one-time issuance of investment-grade senior unsecured bonds early in 2026. The company said it does not expect to issue additional bonds during the calendar year 2026 beyond that transaction. Cloud Infrastructure Revenue Surges 68% As AI Demand Accelerates The announcement follows Oracle's fiscal second-quarter earnings report in December, in which the company posted revenue of $16.06 billion, narrowly missing Wall Street expectations. Adjusted earnings, however, surged 54% year over year to $2.26 per share, easily beating estimates, according to Benzinga Pro. Total revenue rose 14%, fueled by strength in cloud services. Cloud infrastructure revenue jumped 68% to $4.1 billion. Oracle's cloud infrastructure now spans 147 live customer-facing regions, with 64 more regions in the pipeline; the company added nearly 400 megawatts of capacity in the quarter, including a 50% increase in GPU capacity compared with the previous quarter. Strong Guidance Signals Confidence Des...
Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. BeOne Medicines, ticker NasdaqGS:ONC, extended its collaboration with InSysBio to apply mechanistic translational modeling to clinical trial design. The expanded partnership focuses on refining dosing regimens and addressing safety concerns such as cytokine release syndrome. The companies ai...
Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. BeOne Medicines, ticker NasdaqGS:ONC, extended its collaboration with InSysBio to apply mechanistic translational modeling to clinical trial design. The expanded partnership focuses on refining dosing regimens and addressing safety concerns such as cytokine release syndrome. The companies aim to use advanced modeling tools to inform future trial planning and support BeOne Medicines' drug development programs. For you as an investor, this move connects directly to how BeOne Medicines runs its trials and manages risk across its pipeline. The company operates in an industry where immunology and complex biological pathways are central, and modeling approaches like this are becoming more common as drug developers look for data driven ways to design studies. By incorporating more modeling into trial planning, BeOne Medicines is looking to clarify dose selection and safety questions earlier in development, which can be important for patient protection and for keeping studies on track. The extended collaboration with InSysBio gives the company another tool as it prepares future trials, and investors may watch how this is reflected in upcoming study designs and regulatory interactions. Stay updated on the most important news stories for BeOne Medicines by adding it to your watchlist or portfolio. Alternatively, explore our Community to discover new perspectives on BeOne Medicines. NasdaqGS:ONC Earnings & Revenue Growth as at Feb 2026 How BeOne Medicines stacks up against its biggest competitors The extended InSysBio collaboration plugs directly into how BeOne Medicines structures early human studies across its hematology and solid tumor programs, including assets like Brukinsa and sonrotoclax. By using mechanistic translational modeling to set starting doses and step up regimens, the company is trying to frame cytokine release syndrome risk more clearly while still pus...
Computer processor maker AMD (NASDAQ:AMD) will be reporting earnings this Tuesday afternoon. Here’s what you need to know. AMD beat analysts’ revenue expectations by 5.6% last quarter, reporting revenues of $9.25 billion, up 35.6% year on year. It was a strong quarter for the company, with an impressive beat of analysts’ revenue estimates and revenue guidance for next quarter beating analysts’ exp...
Computer processor maker AMD (NASDAQ:AMD) will be reporting earnings this Tuesday afternoon. Here’s what you need to know. AMD beat analysts’ revenue expectations by 5.6% last quarter, reporting revenues of $9.25 billion, up 35.6% year on year. It was a strong quarter for the company, with an impressive beat of analysts’ revenue estimates and revenue guidance for next quarter beating analysts’ expectations. Is AMD a buy or sell going into earnings? Read our full analysis here, it’s free for active Edge members. This quarter, analysts are expecting AMD’s revenue to grow 26.6% year on year to $9.69 billion, improving from the 24.2% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $1.32 per share. AMD Total Revenue Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. AMD has a history of exceeding Wall Street’s expectations, beating revenue estimates every single time over the past two years by 2.4% on average. Looking at AMD’s peers in the processors and graphics chips segment, some have already reported their Q4 results, giving us a hint as to what we can expect. Qorvo delivered year-on-year revenue growth of 8.4%, meeting analysts’ expectations, and Penguin Solutions reported flat revenue, topping estimates by 1.2%. Qorvo traded down 5.6% following the results while Penguin Solutions was also down 13.8%. Read our full analysis of Qorvo’s results here and Penguin Solutions’s results here. There has been positive sentiment among investors in the processors and graphics chips segment, with share prices up 9.6% on average over the last month. AMD is up 7.1% during the same time and is heading into earnings with an average analyst price target of $289.23 (compared to the current share price of $236.79). When a company has more cash than it knows what to do with, buying back its own shares can make a l...
AMD (AMD) To Report Earnings Tomorrow: Here Is What To Expect Computer processor maker AMD (NASDAQ:AMD) will be reporting earnings this Tuesday afternoon. Here’s what you need to know. AMD beat analysts’ revenue expectations by 5.6% last quarter, reporting revenues of $9.25 billion, up 35.6% year on year. It was a strong quarter for the company, with an impressive beat of analysts’ revenue estimat...
AMD (AMD) To Report Earnings Tomorrow: Here Is What To Expect Computer processor maker AMD (NASDAQ:AMD) will be reporting earnings this Tuesday afternoon. Here’s what you need to know. AMD beat analysts’ revenue expectations by 5.6% last quarter, reporting revenues of $9.25 billion, up 35.6% year on year. It was a strong quarter for the company, with an impressive beat of analysts’ revenue estimates and revenue guidance for next quarter beating analysts’ expectations. Is AMD a buy or sell going into earnings? Read our full analysis here, it’s free for active Edge members. This quarter, analysts are expecting AMD’s revenue to grow 26.6% year on year to $9.69 billion, improving from the 24.2% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $1.32 per share. AMD Total Revenue Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. AMD has a history of exceeding Wall Street’s expectations, beating revenue estimates every single time over the past two years by 2.4% on average. Looking at AMD’s peers in the processors and graphics chips segment, some have already reported their Q4 results, giving us a hint as to what we can expect. Qorvo delivered year-on-year revenue growth of 8.4%, meeting analysts’ expectations, and Penguin Solutions reported flat revenue, topping estimates by 1.2%. Qorvo traded down 5.6% following the results while Penguin Solutions was also down 13.8%. Read our full analysis of Qorvo’s results here and Penguin Solutions’s results here. There has been positive sentiment among investors in the processors and graphics chips segment, with share prices up 9.6% on average over the last month. AMD is up 7.1% during the same time and is heading into earnings with an average analyst price target of $289.23 (compared to the current share price of $236.79). When a company has more cash than it ...
Computer processor maker AMD (NASDAQ:AMD) will be reporting earnings this Tuesday afternoon. Here’s what you need to know. AMD beat analysts’ revenue expectations by 5.6% last quarter, reporting revenues of $9.25 billion, up 35.6% year on year. It was a strong quarter for the company, with an impressive beat of analysts’ revenue estimates and revenue guidance for next quarter beating analysts’ exp...
Computer processor maker AMD (NASDAQ:AMD) will be reporting earnings this Tuesday afternoon. Here’s what you need to know. AMD beat analysts’ revenue expectations by 5.6% last quarter, reporting revenues of $9.25 billion, up 35.6% year on year. It was a strong quarter for the company, with an impressive beat of analysts’ revenue estimates and revenue guidance for next quarter beating analysts’ expectations. Is AMD a buy or sell going into earnings? Read our full analysis here, it’s free for active Edge members. This quarter, analysts are expecting AMD’s revenue to grow 26.6% year on year to $9.69 billion, improving from the 24.2% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $1.32 per share. AMD Total Revenue Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. AMD has a history of exceeding Wall Street’s expectations, beating revenue estimates every single time over the past two years by 2.4% on average. Looking at AMD’s peers in the processors and graphics chips segment, some have already reported their Q4 results, giving us a hint as to what we can expect. Qorvo delivered year-on-year revenue growth of 8.4%, meeting analysts’ expectations, and Penguin Solutions reported flat revenue, topping estimates by 1.2%. Qorvo traded down 5.6% following the results while Penguin Solutions was also down 13.8%. Read our full analysis of Qorvo’s results here and Penguin Solutions’s results here. There has been positive sentiment among investors in the processors and graphics chips segment, with share prices up 9.6% on average over the last month. AMD is up 7.1% during the same time and is heading into earnings with an average analyst price target of $289.23 (compared to the current share price of $236.79). When a company has more cash than it knows what to do with, buying back its own shares can make a l...
Computer processor maker AMD (NASDAQ: AMD) will be reporting earnings this Tuesday afternoon. Here’s what you need to know. AMD beat analysts’ revenue expectations by 5.6% last quarter, reporting revenues of $9.25 billion, up 35.6% year on year. It was a strong quarter for the company, with an impressive beat of analysts’ revenue estimates and revenue guidance for next quarter beating analysts’ ex...
Computer processor maker AMD (NASDAQ: AMD) will be reporting earnings this Tuesday afternoon. Here’s what you need to know. AMD beat analysts’ revenue expectations by 5.6% last quarter, reporting revenues of $9.25 billion, up 35.6% year on year. It was a strong quarter for the company, with an impressive beat of analysts’ revenue estimates and revenue guidance for next quarter beating analysts’ expectations. Is AMD a buy or sell going into earnings? Read our full analysis here, it’s free for active Edge members. This quarter, analysts are expecting AMD’s revenue to grow 26.6% year on year to $9.69 billion, improving from the 24.2% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $1.32 per share. Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. AMD has a history of exceeding Wall Street’s expectations, beating revenue estimates every single time over the past two years by 2.4% on average. Looking at AMD’s peers in the processors and graphics chips segment, some have already reported their Q4 results, giving us a hint as to what we can expect. Qorvo delivered year-on-year revenue growth of 8.4%, meeting analysts’ expectations, and Penguin Solutions reported flat revenue, topping estimates by 1.2%. Qorvo traded down 5.6% following the results while Penguin Solutions was also down 13.8%. Read our full analysis of Qorvo’s results here and Penguin Solutions’s results here. There has been positive sentiment among investors in the processors and graphics chips segment, with share prices up 9.6% on average over the last month. AMD is up 7.1% during the same time and is heading into earnings with an average analyst price target of $289.23 (compared to the current share price of $236.79). When a company has more cash than it knows what to do with, buying back its own shares can make a lot of sense–as lo...
Computer processor maker AMD AMDwill be reporting earnings this Tuesday afternoon. Here’s what you need to know. AMD beat analysts’ revenue expectations by 5.6% last quarter, reporting revenues of $9.25 billion, up 35.6% year on year. It was a strong quarter for the company, with an impressive beat of analysts’ revenue estimates and revenue guidance for next quarter beating analysts’ expectations....
Computer processor maker AMD AMDwill be reporting earnings this Tuesday afternoon. Here’s what you need to know. AMD beat analysts’ revenue expectations by 5.6% last quarter, reporting revenues of $9.25 billion, up 35.6% year on year. It was a strong quarter for the company, with an impressive beat of analysts’ revenue estimates and revenue guidance for next quarter beating analysts’ expectations. Is AMD a buy or sell going into earnings? Read our full analysis here, it’s free for active Edge members. This quarter, analysts are expecting AMD’s revenue to grow 26.6% year on year to $9.69 billion, improving from the 24.2% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $1.32 per share. Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. AMD has a history of exceeding Wall Street’s expectations, beating revenue estimates every single time over the past two years by 2.4% on average. Looking at AMD’s peers in the processors and graphics chips segment, some have already reported their Q4 results, giving us a hint as to what we can expect. Qorvo delivered year-on-year revenue growth of 8.4%, meeting analysts’ expectations, and Penguin Solutions reported flat revenue, topping estimates by 1.2%. Qorvo traded down 5.6% following the results while Penguin Solutions was also down 13.8%. Read our full analysis of Qorvo’s results here and Penguin Solutions’s results here. There has been positive sentiment among investors in the processors and graphics chips segment, with share prices up 9.6% on average over the last month. AMD is up 7.1% during the same time and is heading into earnings with an average analyst price target of $289.23 (compared to the current share price of $236.79).
棚網新規|多廈仍有棚無網 總工會:工人傾向年後開工、業主拒歲晚掛網 To view this video please enable JavaScript, and consider upgrading to a web browser that supports HTML5 video 【有線新聞】建造業議會集體為已拆棚網的大廈採購棚網,業界預計全數五萬張棚網農曆年前可以交付承建商。有些大廈收到...
棚網新規|多廈仍有棚無網 總工會:工人傾向年後開工、業主拒歲晚掛網 To view this video please enable JavaScript, and consider upgrading to a web browser that supports HTML5 video 【有線新聞】建造業議會集體為已拆棚網的大廈採購棚網,業界預計全數五萬張棚網農曆年前可以交付承建商。有些大廈收到棚網仍未上網,工會就稱工人要過年後才開工,亦有業主不希望過年期間家居被棚網包圍。 在堅尼地城的安樂大樓,新棚網已經運抵超過一星期仍未上架。建造業議會為418幢樓宇集體採購5萬張棚網,通過阻燃效能測試後,上月中已陸續發放予承建商。近日所見很多大廈依然有棚無網,建造業總工會稱很多工程傾向農曆年後才開工。 香港建造業總工會理事長周思傑:「12月棚網下架後,所有大維修工人也失業,我也聽過有些工人提早回鄉過年。建造業議會派棚網是1月15日,1月15日派棚網至今、至過年也不足一個月,有些業主不希望過年時掛棚網上去。」 有分包商代表預計全數5萬張棚網農曆年前可以到貨分發,若不經建造業議會採購,進度相對不理想。 香港建造業分包商聯會永遠榮譽會長伍新華:「因為現在不是每位都願意做這些生意,國內棚網供應商也擔心交付的棚網有問題,要確定棚網是否合規,大家也在觀望。而建築業議會找到的兩間棚網供應商,到目前為止收到的訊息、供貨沒有問題。」 他建議建造業議會制訂棚網供應商「白名單」供業界參考。